Skip to content

Menu

LexBlog, Inc. logo
CommunitySub-MenuPublishersChannelsProductsSub-MenuBlog ProBlog PlusBlog PremierMicrositeSyndication PortalsAboutContactResourcesSubscribeSupport
Join
Search
Close

The Kratom industry wants the FDA to send down some regulation

By Dan Flynn on September 19, 2023
Email this postTweet this postLike this postShare this post on LinkedIn
Kratom

Import alerts, warning letters, and seizures by U.S. Marshals involving the U.S. Food and Drug Administration (FDA) are not uncommon where Kratom is involved.  The tropical tree native to Southeast Asia is not approved for any medical use by the FDA but is often mentioned for one kind of caution or another.

And court action now has the industry crying out for regulation.

A Florida jury on July 31 awarded  $11 million for the wrongful death of a Florida woman.   She died due to “acute mitragynine intoxication.” Mitragynine, one of two main chemical compounds in kratom, produces classic opioid-like effects at high concentrations, such as sedation, nausea, vomiting, addiction, and difficulty breathing, which may be fatal.

FDA has not approved kratom for sale in the U.S., but the herb operates in a grey area of the law and is often sold online or at convenience stores and gas stations, usually in the form of capsules or loose powder. 

Kratom leaves produces both stimulant effects (in low doses) and sedative effects (in high doses) and can lead to psychotic symptoms and psychological and physiological dependence. Kratom leaves contain two primary psychoactive ingredients (mitragynine and 7-hydroxy mitragynine). 

The leaves are crushed, smoked, brewed with tea, or placed into gel capsules. Kratom has a long history of use in Southeast Asia, where it is commonly known as thang, kakuam, thom, ketum, and biak. In the U.S., kratom abuse has increased markedly in recent years.

However, Kratom is not controlled under the Controlled Substances Act, although there are some state regulations or prohibitions against the possession and use of kratom. 

The Drug Enforcement Agency has listed kratom as a Drug and Chemical of Concern.

It may surprise some that the American Kratom Association (AKA) issued a Consumer Advisory in response to recent wrongful death jury awards in Florida and elsewhere.   The industry group:

1.    Urges the FDA to immediately publish product manufacturing standards for kratom products that are sold to consumers and encourage the removal of kratom products that do not contain adequate labeling with recommended serving sizes, product ingredients, and appropriate warnings on conditions of use.

2.    Until the FDA implements a set of standards to protect consumers, the AKA advises kratom consumers not to purchase or consume kratom products that:
a.    Have not been certified by an independent third-party lab to be free of dangerous contaminants or contain adulterants that could be dangerous to consume.
b.    Are offered for sale from a vendor that markets its product with illegal therapeutic claims.
c.    Do not contain the name of the product distributor so that a consumer can file an adverse event report if required.
d.    Are delivered in unprofessional packaging, such as zip-close bags, or that have handwritten product information.

“Recent reports of product liability awards for irresponsibly manufactured or marketed kratom products are the direct result of the FDA’s failure to regulate the kratom marketplace and, in some cases, the exploitive behavior of trial attorneys who do nothing to compel the FDA to act responsibly,” said Mac Haddow, the AKA’s Senior Fellow on Public Policy.

Based on the AKA’s review of litigation reports, Haddow claims the product liability awards by the courts have been based on the failure of the product manufacturers to provide labeling instructions for responsible use and little or no information on the contents of the potentially contaminated products.

“The safety and addiction profile of pure, unadulterated kratom is well-documented by science and there is no known level of kratom use that would cause any fatality unless it is irresponsibly consumed, adulterated with a toxic drug or used concurrently with a deadly drug substance,” Haddow added. “The AKA supports congressional action to compel the FDA to develop and implement a set of standards for the manufacturing and marketing of kratom products to protect consumers in the United States.”

AKA calls itself  “a consumer-based, nonprofit organization, focuses on setting the record straight about kratom and gives a voice to those suffering by protecting their rights to possess and consume safe and natural kratom.”  It claims to represent “millions of Americans, each of whom has a unique story to tell about the virtues of kratom and its positive effects on their lives.”

(To sign up for a free subscription to Food Safety News, click here.)

Photo of Dan Flynn Dan Flynn

Editor Dan Flynn is a Northern Colorado-based writer and editor with more more than 15 years of food safety experience. As a public affairs professional, he worked with government and regulatory agencies at the local, state, and federal levels. His career as a…

Editor Dan Flynn is a Northern Colorado-based writer and editor with more more than 15 years of food safety experience. As a public affairs professional, he worked with government and regulatory agencies at the local, state, and federal levels. His career as a journalist included working for newspapers throughout the West, from the Black Hills to Seattle. His on-scene reporting on the collapse of the Idaho’s Teton Dam and the suicide bombing at Washington State University’s Perham Hall was carried by newspapers around the world and was recognized both times regionally by the Associated Press for Best Reporting on a Deadline. Most of the disasters he attends these days involve food illnesses.

Email
Show more Show less
  • Posted in:
    Food, Drug & Agriculture, Personal Injury
  • Blog:
    Food Safety News
  • Organization:
    Marler Clark, Inc., PS
  • Article: View Original Source

LexBlog, Inc. logo
Facebook LinkedIn Twitter RSS
Real Lawyers
99 Park Row
  • About LexBlog
  • Careers
  • Press
  • Contact LexBlog
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Terms of Service
  • RSS Terms of Service
  • Products
  • Blog Pro
  • Blog Plus
  • Blog Premier
  • Microsite
  • Syndication Portals
  • LexBlog Community
  • 1-800-913-0988
  • Submit a Request
  • Support Center
  • System Status
  • Resource Center

New to the Network

  • PatentNext
  • Tressler Insurance Law Blog
  • Tressler Employment Law Blog
  • Inside Global Tech
  • Proskauer Whistleblower Defense
Copyright © 2023, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo